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Summary 
Long QT syndrome (LQT) is an inherited disorder that 
causes sudden death from cardiac arrhythmias, spe- 
cifically torsade de pointes and ventricular fibrillation. 
We previously mapped three LQT loci: LQT1 on chro- 
mosome 11p15.5, LQT2 on 7q35-36, and LQT3 on 
3p21-24. Here we report genetic linkage between LQT3 
and polymorphisms within SCN5A, the cardiac sodium 
channel gene. Single strand conformation polymor- 
phism and DNA sequence analyses reveal identical in- 
tragenic deletions of SCN5A in affected members of 
two unrelated LQT families. The deleted sequences 
reside in a region that is important for channel inactiva- 
tion. These data suggest that mutations in SCN5A 
cause chromosome 3-1inked LQT and indicate a likely 
cellular mechanism for this disorder. 
Introduction 
Although sudden death from cardiac arrhythmias is thought 
to account for 11% of all natural deaths, the mechanisms 
underlying arrhythmias are poorly understood (Kannel et 
al., 1987; Willich et al., 1987). Long QT syndrome (LQT) 
is an inherited cardiac arrhythmia that causes abrupt loss 
of consciousness, seizures, and sudden death from ven- 
tricular tachyarrhythmias, pecifically torsade de pointes 
and ventricular fibrillation (Ward, 1964; Romano, 1965; 
Schwartz et al., 1975; Moss et al., 1991). Autosomal domi- 
nant and autosomal recessive forms of this disorder have 
been reported. Autosomal recessive LQT (also known as 
JervelI-Lange-Nielson syndrome) has been associated 
with congenital neural deafness; this form of LQT is rare 
(Jervell and Lange-Nielson, 1957). Autosomal dominant 
LQT (Romano-Ward syndrome) is more common and is 
not associated with other phenotypic abnormalities. A dis- 
order very similar to inherited LQT can also be acquired, 
usually as a result of pharmacologic therapy (Schwartz et 
al., 1975; Zipes, 1987). 
We have used two strategies to identify LQT genes, a 
candidate gene approach and positional cloning. Posi- 
tional information is now available for three LQT loci, as 
we have mapped LQT1 to chromosome 1 lp15.5 (Keating 
et al., 1991 a, 1991 b), LQT2 to 7q35-36, and LQT3 to 3p21- 
24 (Jiang et al., 1994). The candidate gene approach relies 
on likely mechanistic hypotheses based on physiology. 
Although little is known about the physiology of LQT, the 
disorder is associated with prolongation of the QT interval 
on electrocardiograms, a sign of abnormal cardiac repolar- 
ization. This association suggests that genes encoding 
ion channels (or their modulators) are reasonable candi- 
dates for LQT. This hypothesis is now supported by our 
recent discovery that chromosome 7-1inked LQT results 
from mutations in the human ether-a-go-go-related gene 
(HERG), a putative cardiac potassium channel gene (Cur- 
ran et al., 1995 [this issue of Ce//]). A neuroendocrine cal- 
cium channel gene (CACNLIA2; Chin et al., 1991; Seino 
et al., 1992) and agene encoding a GTP-binding protein 
that modulates potassium channels (GNAI2; Weinstein et 
al., 1988; Magovcevic et al., 1992) became candidates for 
LQT3 based on their chromosomal ocation. Subsequent 
linkage analyses, however, have excluded these genes 
(Q. W. and M. T. K., unpublished data). 
In theory, mutations in a cardiac sodium channel gene 
could cause LQT. Voltage-gated sodium channels medi- 
ate rapid depolarization in ventricular myocytes and also 
conduct a small current during the plateau phase of the 
action potential (Attwell et al., 1979). Subtle abnormalities 
of sodium channel function (e.g., delayed sodium channel 
inactivation or altered voltage dependence of channel in- 
activation) could delay cardiac repoiarization, leading to 
QT prolongation and arrhythmias. A few years ago, Gel- 
lens et al. (1992) cloned and characterized a cardiac so- 
dium channel gene, SCN5A. The structure of this gene 
was similar to previously characterized sodium channels, 
encoding a large protein of 2016 amino acids. These chan- 
nel proteins contain four homologous domains (DI-DIV), 
each of which contains six putative membrane-spanning 
segments ($1-$6). SCN5A was recently mapped to chro- 
mosome 3p21, making it an excellent candidate gene for 
LQT3 (George et al., 1995). 
In this study, we provide evidence suggesting that 
SCN5A is LQT3. We used genotypic analyses to show that 
SCN5A was tightly linked to LQT3 in three unrelated fami- 
lies. We then identified the same Jntragenic deletion of 
SCN5A in affected members of two of these families. 
These deletions disrupted sequences within a region of 
known importance for sodium channel inactivation, sug- 




Table 1. PCR Primers Used to Define SCNSA Polymorphisms and Mutations 
Primer Sequence Region Amplified Exon 
1L GCCTGTCTGATCTCCCTGTGTGA DIll/S6; IDIII-IV 21 
2R ACCCAGCCCAGTGGGGAGCTGGT 
3L CCATGCTGGGGCCTCTGAGAAC IDIII-IV 22 
4R GGCTCTGATGGCTGGCCATGTG 
5L CCCAGCGAGCACTTTCCATTTG IDIII-IV; DIV/S1-S3 23 
6R GCTTCTCCGTCCAGCTGACTTGTA 
7L . GAGCCCAGCCGTGGGCATCCT DIV/S6 24 
8R GTCCCCACTCACCATGGGCAG 
All primers are shown in 5' to 3' direction. Sense strand oligonucleotides are indicated with an L and antisense oligonucleotides are indicated with 
an R. D, domain; ID, interdomain; S, membrane-spanning segment. 
Results 
Genetic Linkage of SCNSA and LQT3 
In 1995, SCN5A was mapped to chromosome 3p21 
(George et al., 1995). To test the candidacy of SCNSA for 
LQT, we used single strand conformation polymorphism 
(SSCP) analyses to identify polymorphisms within this 
gene and then performed l inkage analyses in chromo- 
some 3-1inked families. Since the genomic structure of 
SCN5A was unknown, we designed ol igonucleotide primer 
pairs from published SCNSA cDNA sequences (Gellens 
et al., 1992), based on the assumption that the genomic 
structure of SCN5A would be similar to the known structure 
of SCN4A, the skeletal muscle sodium channel gene 
(McClatchey et al., 1992a). Primer pairs that gave appro- 
priately sized products from genomic DNA were used to 
screen DNA samples from patients. An aberrant SSCP 
conformer was identified using primer pair 7-8 (Table 1). 
The normal and aberrant bands were cloned and se- 
quenced. The aberrant conformer resulted from a C to T 
substitution at position 3 of codon 1819 (cDNA nucleotide 
5607; Gellens et al., 1992). This substitution did not affect 
the predicted amino acid sequence of the product of 
SCN5A. The observed heterozygosity for this polymor- 
phism was <0.50. The SCN5A polymorphism was used 
for genotypic analyses in chromosome 3-1inked famil ies 
(Figure 1). No recombination events between SCN5A and 
LQT were identified in any of these families. The maximum 
combined two-point Iod score for all chromosome 3-1inked 
fami l ies  was 2.74 at a recombinat ion  fract ion of 0.0 
(Table 2). 
No additional SSCP anomalies were identified using 
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Figure 1. Genetic Linkage of SCN5A and 
LQT3 
Pedigree structure and genotypic analyses of 
LQT kindreds 2171, 2321, and 2322. Individu- 
als with the characteristic features of LQT, in- 
cluding prolongation of the QT interval on elec- 
trocardiogram and a history of syncope or 
aborted sudden death, are indicated by closed 
circles (females) or closed squares (males). U n- 
affected individuals are indicated by open sym- 
bols, and individuals with an equivocal phe- 
notype are shown as stippled. Deceased 
individuals are indicated by a slash. The results 
of genotypic analyses are shown below each 
symbol. Genotypes for the following LQT3- 
linked polymorphic markers are shown (telo- 
mere to centromere): D3S1298, SCN5A 7-8, 
SCN5A 3-4, and D3S1100. Haplotypes coseg- 
regating with the disease are indicated by a 
box. Recombination events are indicated by a 
horizontal black line. Haplotype analyses indi- 
cate that LQT3 and SCN5A are tightly linked in 
all chromosome 3-1inked families. 
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Table 2. Pairwise Lod Scores and Recombination Fractions for Linkage of LQT3 with SCN5A 
Recombination Fractions 
Marker Kindred 0.001 0.01 0.05 0.10 0.20 0.30 0.40 
SCN5A 3-4 
SCN5A 7-8 
K2171 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
K2321 1.50 1.47 1.35 1.20 0.87 0.53 0.18 
K2322 4.03 3.95 3.62 3.20 2.34 1.47 0.61 
Total" 5.53 5.43 4.97 4.40 3.22 2.00 0.79 
K2171 0.82 0.80 0.74 0.65 0.46 0.26 0.08 
K2321 0.12 0.12 0.10 0.08 0.04 0.02 0.00 
K2322 1.80 1.78 1.66 1.48 1.05 0.60 0.20 
TotaP 2.74 2.70 2.50 2.20 1.55 0.87 0.28 
Lod scores were calculated assuming autosomal dominant inheritance with a penetrance of 0.90 for all kindreds, as indicated by segregation 
analysis of these and other LQT kindreds. We assumed a disease allele frequency of 0.001 and that female and male recombination frequencies 
were equal. When penetrance was varied from 70%-100%, the maximum combined two-point Iod score for linkage between SCN5A 3-4 and 
LQT3 ranged from 4,85 to 5.91, respectively. The results for SCN5A 7-8 varied from 2.26 (700/0) to 3.01 (100%). 
Z,,~ = 5.54, 0 = 0.00; Z~ indicates maximum Iod score, e indicates estimated recombination fraction at Zm,=. 
b Z,,~., = 2.74, 0 = 0.00. 
cDNA sequences. To facilitate this work, we isolated and 
partially characterized two genomic P1 clones. These 
clones spanned the entire gene and were used to begin 
determining the genomic structure of SCN5A. We hypothe- 
sized that LQT-causing mutations would be subtle (e.g., 
missense mutations or small in-frame deletions) and might 
affect delayed inactivation of encoded sodium channels 
or alter the voltage dependence of channel inactivation. 
We focused, therefore, on regions of known importance 
for channel inactivation. Primers based on sequences pre- 
dicted to encode the cytoplasmic region between Dill and 
DIV were synthesized. This region corresponds to exons 
21-23 of SCN4A and is known to be critical for channel 
inactivation. These primers were used to characterize the 
flanking introns by cycle sequencing. Additional primers 
were designed to these intronic sequences (see Table 1). 
When primer pair 3-4  was used in SSCP analyses, an 
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Figure 2. SCN5A Intragenic Deletion Cosegregates with the Disease 
in Kindred 2321 
The pedigree structure for kindred 2321 is shown. The results of poly- 
merase chain reaction (PCR) analyses using primer pair 3-4 and dena- 
turing polyacrylamide gel electrophoresis are shown below each sym- 
bol. Note that the 235 bp allele cosegregates with t e disease in this 
family, indicating the presence of a disease-associated intragenic dele- 
tion of SCN5A. To avoid phenotypic misclassification, the phenotypic 
criteria used in this study were stringent, and many individuals were 
classified as having an uncertain phenotype. Individuals with a QTc 
of 0.47 s or greater were classified as affected, whereas individuals 
with a QTc of 0.41 s or less were considered unaffected. All other 
individuals were classified as uncertain. If typical criteria were used 
(individuals With a QTc of 0.44 s or greater considered affected and 
individuals with a QTc less than 0.44 s classified as normal), all affected 
members of kindreds 2321 and 2322 would carry the SCN5A deletion 
and all unaffected individuals would carry only the normal allele. 
anomalous conformer was identified in DNA samples from 
affected members of kindreds 2321 and 2322 (Figure 1). 
By contrast, only the normal conformer was seen in DNA 
samples from unaffected members of these families. The 
combined two-point Iod score for linkage between this 
anomaly and LQT3 was 5.54 (Table 2). Again, no recombi- 
nation was observed between SCN5A and LQT3, indicat- 
ing that these loci are tightly linked. 
Identical SCN5A Intragenic Deletions Associated 
with LQT in Two Unrelated Families 
The mobility shift between the aberrant and normal SSCP 
conformers identified in kindreds 2321 and 2322 was 
large, suggesting the possibility of a small deletion. To 
test this hypothesis, the conformers were separated by 
electrophoresis on denaturing polyacrylamide gels (Fig- 
ures 2 and 3). These data demonstrated the presence of 
two products of 235 bp and 244 bp. The 235 bp product 
was only seen in affected individuals. Furthermore, this 
aberrant conformer was not observed in more than 500 
control individuals (data not shown). These data indicate 
that an intragenic deletion of SCNSA is the likely cause 
of LQT in these families. 
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Figure 3. SCN5A Intragenic Deletion i Kindred 2322 
The results of PCR analyses using primer pair 3-4 and denaturing 
polyacrylamide gel electrophoresis are shown below each symbol. 
Note that the 235 bp allele cosegregates with the disease in this family, 
indicating the presence of a disease-associated intragenic deletion. 
The individuals represented in lanes 4 and 8 carried the deletion but 
were phenotypically classified as uncertain. These individuals had  
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Figure 4. DNA and Amino Acid Sequence of the SCNSA Intragenic 
Deletion Associated with LQT 
(A) DNA sequence analysis of the SCN5A intragenic deletion identified 
in kindred 2322. DNA sequence of normal and aberrant PCR products 
defines a 9 bp deletion. This mutation causes a deletion of three amino 
acids (KPQ) in the cytoplasmic rag!on between Dill and DIV. Deleted 
sequences are indicated. 
(B) Amino acid sequence homology of the cytoplasmic region between 
Dill and DIV of sodium channels. Sequences were obtained from Gen- 
Bank. 
To determine the effect of the LQT-associated deletion 
on SCNSA structure, we amplified the normal and aberrant 
SSCP conformers and performed cycle sequencing. These 
experiments revealed the presence of a 9 bp deletion be- 
ginning at nucleotide 4661 of the cDNA (Figure 4A). We 
also cloned and sequenced the aberrant and normal SSCP 
conformers. These experiments confirmed the size and 
location of the deletion. This deletion disrupts the coding 
sequence, resulting in a deletion of three conserved amino 
acids, Lys-1505-Pro-1506-GIn-1507 (KPQ), in the cyto- 
plasmic linker between Dill and DIV (Figures 4B and 5). 
DNA sequence analyses of the aberrant conformer in 
kindred 2321 indicated that the intragenic deletion was 
identical to that found in kindred 2322 (data not shown). 
One possible explanation for the identical deletions in 
these two kindreds is that they are distantly related. Both 
families were North American of European descent, one 
German and the other English. Examination of a geneal- 
ogy data base failed to reveal a relationship between these 
families for more than eight generations. Furthermore, ge- 
notypic analyses of these kindreds indicated different hap- 
Iotypes on the disease chromosome (see Figure 1). The 
presence of identical deletions in two apparently unrelated 
LQT families strongly suggests that SCNSA is LQT3. 
Discussion 
We conclude that mutations in the cardiac sodium channel 
gene SCN5A are the likely cause of chromosome 3-1inked 
DI DII Dill DIV 
,,11111  ,, IIII1 1 IIII1 1 IIII1 1 
3 
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Figure 5. Schematic Representation of the Predicted Topology of the 
Protein Encoded by SCN5A and of the Location of the LQT-Associated 
Deletion 
LQT. Several lines of evidence support this conclusion. 
First, we identified genetic linkage between SCN5A and 
LQT3 in three unrelated families. No recombination was 
identified between these loci. Second, we identified identi- 
cal intragenic deletions of SCNSA in affected members of 
two LQT families. This deletion was not identified in more 
than 500 control individuals. Third, SCNSA is the cardiac 
sodium channel gene. Subtle mutations of this gene would 
be expected to cause an LQT phenotype. Finally, the type 
(an in-frame deletion of three amino acids) and location 
(a region of known importance for sodium channel inacti- 
vation) of the deletions support the conclusion that SCN5A 
is LQT3. 
Additional evidence supports a role for SCN5A in the 
pathogenesis of LQT. Pharmacologic data, for example, 
suggest that abnormal cardiac sodium channel function 
could cause LQT. Toxins and drugs that slow the rate 
of sodium channel inactivation or that shift the voltage 
dependence of channel activation or inactivation can pro- 
long cardiac action potential duration and induce arrhyth- 
mias (Honerjager, 1982). Molecular genetic studies also 
support a link between sodium channel inactivation and 
clinical electrophysiologic abnormalities. Studies of hyper- 
kalemic periodic paralysis and paramyotonia congenita 
indicate that missense mutations in the skeletal muscle 
sodium channel gene (SCN4A) cause myotonia (Fontaine 
et al., 1990; Ptacek et al., 1991, 1992; Rojas et al., 1991; 
McClatchey et al., 1992b, 1992c; Ebers et al., 1991; Ru- 
dolph et al., 1992; Lerche et al., 1993). Physiologic data 
show that these mutations affect sodium channel inactiva- 
tion, leading to repetitive depolarizations, consistent with 
the myotonic phenotype (Yang et al., 1994). By analogy, 
similar mutations in the cardiac sodium channel gene 
could cause a phenotype like LQT. 
We have also demonstrated that mutations in HERG, a 
SCN5A Mutations Associated with Long QT Syndrome 
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putative cardiac potassium channel gene, cause the chro- 
mosome 7-1inked form of LQT (Curran et al., 1995). The 
mutations that we identified in HERG, along with the bio- 
physics of potassium channel ~ subunits, suggest that 
chromosome 7-1inked LQT results from dominant nega- 
tive mutations and a resultant reduction in functional chan- 
nels. In chromosome 3-1inked LQT, by contrast, the LQT- 
associated deletions identified in SCN5A are likely to result 
in functional cardiac sodium channels with altered proper- 
ties, such as delayed inactivation or altered voltage depen- 
dence of channel inactivation. Delayed sodium channel 
inactivation would increase inward sodium current, depo- 
larizing the membrane. This effect is similar to the altered 
membrane potential expected from HERG mutations, in 
which outward potassium current is decreased. It is un- 
likely that more deleterious mutations of SCN5A would 
cause LQT. A reduction of the total number of cardiac 
sodium channels, for example, would be expected to re- 
duce action potential duration, a phenotype opposite that 
of LQT. The mutations described in this study cause the 
deletion of three amino acids, KPQ, in the cytoplasmic 
linker between Dill and DIV. The KPQ sequence is highly 
conserved, suggesting the presence of genetic pressure 
for its conservation during evolution (Figure 4B). The cyto- 
plasmic peptide segment that links Dill and DIV is the 
region responsible for fast inactivation (West et al., 1992). 
Heterologous expression of neural sodium channels in the 
form of two polypeptides lacking this DIII-DIV linker results 
in a sodium current with greatly slowed inactivation 
(Stuhmer et al., 1989). Site-directed mutagenesis tudies 
of this region in SCN4A have focused on another amino 
acid triplet, Ile-1488-Phe-1489-Met-1490 (IFM). Muta- 
tions of these amino acids to glutamine residues eliminate 
sodium channel fast inactivation, but leave slow inactiva- 
tion intact (West et al., 1992). It will be of interest o deter- 
mine whether the KPQ deletion has a similar functional 
effect on cardiac sodium channel inactivation. 
Our data predict a likely cellular mechanism for chromo- 
some 3-1inked LQT. Delayed myocellular sodium channel 
inactivation would prolong action potential duration and 
the QT interval. Excessive prolongation could result in re- 
activation of L-type calcium or sodium channels, thereby 
leading to secondary depolarizations, a likely mechanism 
of torsades de pointes (Antzelevitch and Sicouri, 1994). 
We have not yet identified a mutation in SCN5A in kin- 
dred 2171, the third chromosome 3-1inked LQT family. 
Although the disease phenotype in this kindred appears 
to be linked to SCN5A, SSCP analyses of sequences en- 
coding the putative inactivation region failed to show a 
deletion or other anomalies. Presumably, the disease in 
this family results from SCN5A mutations in another region 
of this approximately 35 kb gene. Mutational analyses of 
hyperkalemic periodic paralysis and paramyotonia con- 
genita families have demonstrated several other regions 
of SCN4A that are important for channel inactivation (Fon- 
taine et al., 1990; Ptacek et al., 1991, 1992; Rojas et al., 
1991; McClatchey et al., 1992b, 19~2c; Ebers et al., 1991 ; 
Rudolph et al., 1992; Lerche et al., 1993). Once we have 
determined the genomic structure of SCN5A, we will 
screen for additional LQT-causing mutations. 
Although LQT kindreds 2321 and 2322 appear unre- 
lated, both had the same KPQ deletion. The haplotype of 
the affected chromosome in each family was distinct, but 
this does not exclude the possibility of a distant relation- 
ship. Continued genotypic analysis of sequences near 
SCN5A may help determine whether these deletions are 
distinct. 
Presymptomatic diagnosis of LQT has depended on 
identification of QT prolongation on electrocardiograms. 
Unfortunately, electrocardiograms are rarely performed in 
young, healthy individuals. In addition, many LQT gene 
carriers have relatively normal QT intervals, and the first 
sign of disease can be a fatal cardiac arrhythmia (Vincent 
et al., 1992). Now that two LQT genes have been identified, 
we can begin to contemplate genetic testing for this disor- 
der. This will require continued mutational analyses and 
identification of additional LQT genes. With more detailed 
phenotypic analyses, we may also discover phenotypic 
differences among the varied forms of LQT. These differ- 
ences may be useful for diagnosis and treatment. 
In summary, we have identified a gene, SCN5A, that is 
likely to cause LQT. Along with our finding that mutations 
in HERG cause the chromosome 7-1inked form of LQT, 
this discovery further supports the hypothesis that LQT 
results from mutations in cardiac ion channels. 
Experimental Procedures 
LQT Kindreds 
This investigation was performed on three previously described LQT 
kindreds (Jiang et al., 1994). Phenotypic riteria were identical to those 
used in our previous tudies (Keating et al., 1991a, 1991b; Keating, 
1992). Individuals were evaluated for LQT based on the QT interval 
corrected for heart rate (QTc; Bazette, 1920) and on the presence of 
syncope, seizures, and aborted sudden death. Informed consent was 
obtained from individuals or their guardians, in accordance with local 
institutional review board guidelines. Phenotypic data were interpreted 
without knowledge of genotype. 
Linkage Analyses 
Pairwise linkage analysis was performed using MLINK in LINKAGE 
version 5.1 (Lathrop et al., 1985). As in our previous tudies, we as- 
sumed a penetrance of 0.90 and an LQT gene frequency of 0.001 
(Keating et al., 1991a, 1991b). Gene frequency was assumed to be 
equal between males and females. 
Isolation of SCNSA Genomic Clones and Partial 
Characterization of Genomic Structure 
SCN5A probes we re generated using the products of PCRs with human 
genomic DNA and primer pairs based on SCN5A cDNA sequences. 
One primer pair, 5'-ACTTTCATCGTACTGAATAAAGGCAA-3' and 
5'-GAGTGAACCAGAATCI-rCACA G C-3', was designed from 5'coding 
sequences and yielded the predicted product of 118 bp. The second 
primer pair, 5'-GGACCGTGAGTCCATCGTGTGA-3' and 5'-AGCCCA- 
TTCACAACATATACAGTCT-3', was derived from the 3' noncoding 
sequences and yielded a product of 336 bp. The third primer pair, 
5'-AGCAACI-ICATCCCAGCTGCTGAG-3' and 5'-CTCCCAGCATC- 
TCAGGTCAAGTG-3', was based on 3' noncoding sequences and 
yielded a product of 297 bp. These PCR products were purified from 
2% agarose gels, radiolabeled to high specific activity, and used to 
screen a human genomic P1 library (Sternberg, 1990). 
To characterize the genomic structure of SCN5A exons encoding 
the cytoplasmic linker between DIII-DIV, we designed sequencing 
primers based on cDNA sequences and predicted genomic structure 
(McClatchey et al., 1992a; Gellens et al., 1992). The primer pair for 
presumed exon 21 (based on the structure of SCN4A) was 5'-TATG- 
AAGAGCAGCCTCAGTGGGAA-3' and 5'-CI I I I I CFFCTGTFGGTT- 
Cell 
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GAAGTTG-3'. Primers for presumed exon 22 were 5'-TTAGGGG- 
GCCAGGACATCTTC-3' and 5'-CAGGGGCCGTGGGATGGGCTTC- 
TGG-3'. Primers for presumed exon 23 were 5'-CACCATATTCAAGCA- 
GATCAG-3' and 5'-CTGCGCCACTACTACTTCACC-3'. These primers 
were used to determine intronic sequences from SCN5A clones as 
described previously (Wang and Keating, 1994). 
SSCP Analyses 
Genomic DNA samples were amplified by PCR and used in SSCP 
analyses as described previously (Orita et al., 1989). Primer pairs used 
for this study are shown in Table 1. Annealing temperature was 62°C 
for all PCRs. Reactions (10 p.I) were diluted with 50 p~l of 0.1% SDS 
and 1 mM EDTA and 50 pl of 95% formamide dye. Diluted products 
were denatured by heating at 94°C for 10 min, and 5 p.I of each sample 
was separated by electrophoresis on 10% nondenaturing polyacryl- 
amide gels (50:1 acrylamide:bisacrylamide) at 4°C. Electrophoresis 
was carried out at 50 W for 2-5 hr. Gels were transferred to 3MM filter 
paper, dried, and exposed to X-ray film at -80°C for 12 hr. 
Sequence Analyses of SSCP Conformers 
Normal and aberrant SSCP conformers were cut directly from dried 
gels and eluted in 100 pl of distilled water at 65°C for 30 min. The 
eluted DNA (10 p.I) was used as template for a second PCR using the 
original primer pair. Products were fractionated in 2% low melting 
temperature agarose gels (FMC Corporation), and DNA fragments 
were purified and sequenced directly by cycle sequencing (Wang and 
Keating, 1994). Alternatively, purified PCR products were cloned into 
pBluescript II SK(+) (Stratagene) using the T-vector method as de- 
scribed previously (Marchuk et al., 1990). Plasmid DNA samples were 
purified and sequenced by the dideoxy chain termination method using 
SequiTherm polymerase (Epicentre Technologies). 
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